Clifford Swan Investment Counsel LLC Sells 4,108 Shares of Colgate-Palmolive Company $CL

Clifford Swan Investment Counsel LLC lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 2.7% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 147,557 shares of the company’s stock after selling 4,108 shares during the period. Clifford Swan Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $13,413,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. Westend Capital Management LLC grew its position in Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 140 shares during the last quarter. Cornerstone Planning Group LLC raised its position in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after purchasing an additional 287 shares during the last quarter. Saudi Central Bank acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at about $29,000. Ransom Advisory Ltd bought a new stake in shares of Colgate-Palmolive during the first quarter worth about $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Colgate-Palmolive in the first quarter valued at approximately $37,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $79.86 on Thursday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a twelve month low of $76.68 and a twelve month high of $100.18. The company has a fifty day moving average of $81.59 and a 200-day moving average of $87.08. The firm has a market capitalization of $64.54 billion, a P/E ratio of 22.43, a P/E/G ratio of 4.61 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $0.91 earnings per share. The business’s revenue was up 1.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is currently 58.43%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Bank of America reduced their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Raymond James Financial cut their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Barclays lowered their target price on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Finally, Wells Fargo & Company decreased their price target on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.